Institute of Reproductive and Developmental Biology, Imperial College School of Medicine, Chelsea and Westminster Hospital, London, United Kingdom.
Department of Women and Children's Health, School of Life Course Sciences, Kings College London, London, United Kingdom.
PLoS One. 2020 Dec 1;15(12):e0239937. doi: 10.1371/journal.pone.0239937. eCollection 2020.
Our previous work has shown myometrial PKA activity declines in term and twin-preterm labour in association with an increase in the expression of the oxytocin receptor (OTR). Here we investigate the action of cAMP/PKA in basal conditions, with the addition of progesterone (P4) and/or IL-1β to understand how cAMP/PKA acts to maintain pregnancy and whether the combination of cAMP and P4 would be a viable therapeutic combination for the prevention of preterm labour (PTL). Further, given that we have previously found that cAMP enhances P4 action we wanted to test the hypothesis that changes in the cAMP effector system are responsible for the functional withdrawal of myometrial P4 action. Myometrial cells were grown from biopsies obtained from women at the time of elective Caesarean section before the onset of labour. The addition of forskolin, an adenylyl cyclase activator, repressed basal OTR mRNA levels at all doses and P4 only enhanced this effect at its highest dose. Forskolin repressed the IL-1β-induced increase in OTR mRNA and protein levels in a PKA-dependent fashion and repressed IL-1β-activation and nuclear transfer of NFκB and AP-1. P4 had similar effects and the combination P4 and forskolin had greater effects on OTR and NFκB than forskolin alone. While PKA knockdown had no effect on the ability of P4 to repress IL-1β-induced OTR expression it reversed the repressive effect of the combination of P4 and forskolin and resulted in a greater increase than observed with IL-1β alone. These studies suggest that cAMP acts via PKA to repress inflammation-driven OTR expression, but that when PKA activity is reduced, the combination of cAMP and P4 actually enhances the OTR response to inflammation, promoting the onset of labour and suggesting that changes in the cAMP effector system can induce a functional P4 withdrawal.
我们之前的工作表明,在足月和双胎早产中,子宫肌层 PKA 活性下降,同时催产素受体(OTR)的表达增加。在这里,我们研究了 cAMP/PKA 在基础条件下的作用,并添加了孕激素(P4)和/或 IL-1β,以了解 cAMP/PKA 如何维持妊娠,以及 cAMP 和 P4 的组合是否是预防早产(PTL)的可行治疗组合。此外,鉴于我们之前发现 cAMP 增强了 P4 的作用,我们想验证一个假设,即 cAMP 效应系统的变化是导致子宫肌层 P4 作用功能丧失的原因。我们从择期剖宫产妇女的活检中获取子宫肌细胞,这些妇女在分娩前没有出现临产症状。添加 forskolin(一种腺苷酸环化酶激活剂)可抑制所有剂量的基础 OTR mRNA 水平,而 P4 仅在最高剂量时增强这种作用。 forskolin 以 PKA 依赖性方式抑制 IL-1β 诱导的 OTR mRNA 和蛋白水平增加,并抑制 IL-1β 激活和 NFκB 和 AP-1 的核转移。P4 具有相似的作用,P4 和 forskolin 的组合对 OTR 和 NFκB 的作用大于 forskolin 单独作用。虽然 PKA 敲低对 P4 抑制 IL-1β 诱导的 OTR 表达的能力没有影响,但它逆转了 P4 和 forskolin 组合的抑制作用,导致比单独用 IL-1β 观察到的增加更大。这些研究表明,cAMP 通过 PKA 抑制炎症驱动的 OTR 表达,但当 PKA 活性降低时,cAMP 和 P4 的组合实际上增强了 OTR 对炎症的反应,促进了分娩的开始,并表明 cAMP 效应系统的变化可以诱导 P4 功能丧失。